ZA955761B - Marek's disease virus vaccine - Google Patents

Marek's disease virus vaccine

Info

Publication number
ZA955761B
ZA955761B ZA955761A ZA955761A ZA955761B ZA 955761 B ZA955761 B ZA 955761B ZA 955761 A ZA955761 A ZA 955761A ZA 955761 A ZA955761 A ZA 955761A ZA 955761 B ZA955761 B ZA 955761B
Authority
ZA
South Africa
Prior art keywords
marek
disease virus
virus vaccine
vaccine
disease
Prior art date
Application number
ZA955761A
Other languages
English (en)
Inventor
William Baxendale
Original Assignee
Akzo Nobel Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel Nv filed Critical Akzo Nobel Nv
Publication of ZA955761B publication Critical patent/ZA955761B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/245—Herpetoviridae, e.g. herpes simplex virus
    • A61K39/255—Marek's disease virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16311—Mardivirus, e.g. Gallid herpesvirus 2, Marek-like viruses, turkey HV
    • C12N2710/16334—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/82—Proteins from microorganisms
    • Y10S530/826—Viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Epidemiology (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
ZA955761A 1994-07-14 1995-07-11 Marek's disease virus vaccine ZA955761B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP94202047 1994-07-14

Publications (1)

Publication Number Publication Date
ZA955761B true ZA955761B (en) 1996-02-21

Family

ID=8217038

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA955761A ZA955761B (en) 1994-07-14 1995-07-11 Marek's disease virus vaccine

Country Status (8)

Country Link
US (1) US5686287A (xx)
JP (1) JPH0851974A (xx)
KR (1) KR960004513A (xx)
CA (1) CA2153760A1 (xx)
HU (1) HU217890B (xx)
IL (1) IL114501A (xx)
NZ (1) NZ272548A (xx)
ZA (1) ZA955761B (xx)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5928648A (en) * 1985-09-06 1999-07-27 Syntro Corporation Recombinant herpesvirus of turkeys and uses thereof
US6913751B2 (en) * 1992-06-12 2005-07-05 Schering-Plough Veterinary Corporation Recombinant avian herpesvirus useful in vaccine production
US6048535A (en) 1997-06-12 2000-04-11 Regents Of The University Of Minnesota Multivalent in ovo avian vaccine
EP1027426A4 (en) * 1997-10-31 2006-04-19 Merck & Co Inc METHOD FOR IMPROVED MIXING OF A VARICELLA INFECTED CELL CULTURE IN ROLL BOTTLES
US7314715B2 (en) 2001-06-14 2008-01-01 Schering-Plough Animal Health Corporation Recombinant avian herpesvirus useful in vaccine production
US20070111211A1 (en) * 2003-12-30 2007-05-17 Virumar Pituach Tarkivim Ltd. Integrated viral complexes, methods of production thereof, vaccines containing same and methods of use thereof
EP1848541A4 (en) * 2005-02-07 2013-01-16 Pharmalight Inc METHOD AND DEVICE FOR OPHTHALMIC DELIVERY OF PHARMACEUTICALLY ACTIVE INGREDIENTS

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL8401120A (nl) * 1984-04-09 1985-11-01 Centraal Diergeneeskundig Inst Viruspreparaat, waarmee gevaccineerd kan worden tegen de ziekte van marek.
US4895718A (en) * 1987-07-10 1990-01-23 The United States Of America, As Represented By The Secretary Of Agriculture Serotype 2 Marek's disease vaccine
US4895717A (en) * 1987-07-10 1990-01-23 The United States Of America As Represented By The Secretary Of Agriculture Revertant serotype 1 Marek's disease vaccine
EP0486106A3 (en) * 1990-11-16 1992-12-23 Akzo N.V. Marek's disease virus vaccine
IL100386A (en) * 1990-12-24 1995-07-31 Akzo Nv Suitable free vaccine against virus
US5849299A (en) * 1991-06-28 1998-12-15 The United States Of America As Represented By The Secretary Of Agriculture Attenuated revertant serotype 1 marek's disease vaccine

Also Published As

Publication number Publication date
HU9502128D0 (en) 1995-09-28
CA2153760A1 (en) 1996-01-15
KR960004513A (xx) 1996-02-23
JPH0851974A (ja) 1996-02-27
IL114501A0 (en) 1995-11-27
HU217890B (hu) 2000-06-28
IL114501A (en) 1999-08-17
HUT72921A (en) 1996-06-28
NZ272548A (en) 1996-09-25
US5686287A (en) 1997-11-11

Similar Documents

Publication Publication Date Title
PL331236A1 (en) Polynucleotidic vaccine composition against cattle's respiratory system diseases
ZA915563B (en) Recombinant marek's disease virus
EP0486106A3 (en) Marek's disease virus vaccine
ZA989365B (en) Preparation for treating alzheimer's disease
NZ298224A (en) Recombinant papilloma virus antigens
PL319294A1 (en) Dna encoding the human papilloma virus of 6 a type
GB9420146D0 (en) Papillomavirus vaccine
AU657962B2 (en) Recombinant fowlpox vaccine for protection against Marek's disease
IL128847A0 (en) Immunogenic peptides of foot-and-mouth disease viruses
EP0775743A3 (en) Chicken cell liquid infected with Marek's disease virus
IL114501A (en) Marek's disease virus vaccine
ZA964878B (en) Marek's disease vaccine
EP1064947A4 (en) IN OVO VACCINATION AGAINST MAREK'S DISEASE VIRUS, TYPE 1
GB2331521B (en) Vaccine preparations
GB2317800B (en) Angler's weight
GB2292057B (en) Angler's aid
ZA903142B (en) Canine corona virus vaccine
IL115197A0 (en) Vaccine preparations
GB9702990D0 (en) Virus vaccine
GB9509425D0 (en) "Virus"
GB9419969D0 (en) Vaccine
RO101947B1 (en) Marek's disease vaccine and preparation method
GB9620856D0 (en) Virus vaccine
AU2521899A (en) A virus vaccine of enhanced immunogenicity against aujeszky's disease
AU2230295A (en) Human neurological disease virus